the scripps research institute

New test from Transplant Genomics will spot organ rejection as soon as it starts

It was Dr. Stanley Rose’s own kidney transplant that sparked the idea for Transplant Genomics, a company that’s finding a better way to test early on for organ graft rejection. “As an organ transplant recipient, myself, I know that once you wake up from surgery from day one you’re wondering, ‘How am I doing?'” Rose said. […]

By Meghana Keshavan

A Deep-dive Into Specialty Pharma

A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.

By PurpleLab

A Personalized Approach to Medication Nonadherence

At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.